Recent genomic studies have found that TP53 gene mutations remain the most common genetic alteration in both OAC19, 20 and its precursor lesion BO with dysplasia,21 with wild-type TP53 estimated to be present in only approximately 30% of OAC tumours. The gene discussed is TP53; the disease is neoplasm.